Curevac N.V. (NQ: CVAC )
3.640
+0.040
(+1.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 25, 2024
Add to My Watchlist
Press Releases about Curevac N.V.
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
CureVac Announces Proposed Public Offering of Common Shares
February 07, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
CureVac Welcomes Myriam Mendila as New Chief Development Officer
February 01, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
January 09, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
CureVac Announces Voting Results of General Meeting
June 22, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update
May 25, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
April 28, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
March 30, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.